AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: Lechat, P Lardoux, H Mallet, A Sanchez, P Derumeaux, G Lecompte, T Maillard, L Mas, JL Mentre, F Pousset, F Lacomblez, I Pisica, G Solbes-Latourette, S Raynaud, P Chaumet-Riffaud, P
Citation: P. Lechat et al., Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation - A randomized trial (fluindione, fibrillation auriculaire, aspirin et contraste spontane; FFAACS), CEREB DIS, 12(3), 2001, pp. 245-252

Authors: Gerotziafas, GT Elalamy, I Lecrubier, C Lebrazi, J Mirshahi, M Potevin, F Lecompte, T Samama, MM
Citation: Gt. Gerotziafas et al., The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia, BL COAG FIB, 12(7), 2001, pp. 511-520

Authors: Leret, N Cortney, A Maillard, C Rouabah, M Hascoet, JM Lecompte, T de Maistre, E
Citation: N. Leret et al., Neonatal vein thrombosis in a heterozygous carrier of both factor V Leidenand prothrombin mutations, ARCH PED, 8(11), 2001, pp. 1222-1225

Authors: Ghiringhelli, CB Rabaud, C Lecompte, T Labouyrie, C Siatte, J May, T
Citation: Cb. Ghiringhelli et al., Bronchiolitis oblierans with pneumonic organization, MED MAL INF, 31(1), 2001, pp. 35-36

Authors: Lecompte, T
Citation: T. Lecompte, What's new after protein Z and its associate ZPI?, J MAL VASC, 26(4), 2001, pp. 221-222

Authors: Vallar, L Regnault, V Latger-Cannard, V Lecompte, T
Citation: L. Vallar et al., beta(2)-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa, THROMB HAEM, 85(2), 2001, pp. 314-319

Authors: Bibes, B Lecompte, T Dodinot, B Schuhmacher, H Rabaud, C May, T
Citation: B. Bibes et al., Bacterial infection as complication in pacemaker wearers, REV MED IN, 22, 2001, pp. 287S-288S

Authors: Figarella, I Barbaud, A Lecompte, T De Maistre, E Reichert-Penetrat, S Schmutz, JL
Citation: I. Figarella et al., Cutaneous delayed hypersensitivity reactions to heparins and heparinoids., ANN DER VEN, 128(1), 2001, pp. 25-30

Authors: Toussaint, M Latger-Cannard, V Caron, A Lecompte, T Stoltz, JF Vigneron, C Menu, P
Citation: M. Toussaint et al., Effects of three Hb-based oxygen-carrying solutions on neutrophil activation in vitro: quantitative measurement of the expression of adherence receptors, TRANSFUSION, 41(2), 2001, pp. 226-231

Authors: Latger-Cannard, V Sommelet, D Guerci, B Trechot, P Lecompte, T
Citation: V. Latger-cannard et al., Platelet gigantism associated with cholestyramine therapy, ARCH IN MED, 161(21), 2001, pp. 2619-2620

Authors: de Maistre, E Regnault, V Lecompte, T Scheid, P Martinet, Y Bellou, A Amiral, J Vissac, AM
Citation: E. De Maistre et al., Antibodies to interleukin-8 and paraneoplastic catastrophic recurrent thromboses, AM J MED, 111(7), 2001, pp. 580-581

Authors: de Moerloose, P Lecompte, T
Citation: P. De Moerloose et T. Lecompte, Aspirin and stroke prevention, DRUG THERAPY FOR STROKE PREVENTION, 2001, pp. 35-48

Authors: Guermazi, S Regnault, V Gorgi, Y Ayed, K Lecompte, T Dellagi, K
Citation: S. Guermazi et al., Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus, BL COAG FIB, 11(5), 2000, pp. 491-498

Authors: Lecompte, T Deschamps, JC Bourrieres, JP
Citation: T. Lecompte et al., A data model for generalized scheduling for virtual enterprise, PROD PLAN C, 11(4), 2000, pp. 343-348

Authors: Longrois, D de Maistre, E Bischoff, N Dopff, C Meistelman, C Angioi, M Lecompte, T
Citation: D. Longrois et al., Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia, CAN J ANAES, 47(3), 2000, pp. 255-260

Authors: Latger-Cannard, V Regnault, V Dumas, D Nguyen, P Lecompte, T Stoltz, JF
Citation: V. Latger-cannard et al., Determination of polymorphonuclear neutrophil adhesion receptors: Influence of pre-analytic factors., J MAL VASC, 25(3), 2000, pp. 181-186

Authors: Marechal, V De Maistre, E Barbaud, A Albuisson, E Lecompte, T Gobert, B Bene, MC Faure, GC Schmutz, JL
Citation: V. Marechal et al., Activated protein C resistance and cardiolipin antibodies in leg ulcers., ANN DER VEN, 127(6-7), 2000, pp. 585-589

Authors: Lesesve, JF Goupil, JJ Latger, V Buisine, J Lecompte, T
Citation: Jf. Lesesve et al., Artefactual elevation of the automated white cell count in the context of a bone marrow aspirate analysis, CLIN LAB H, 22(1), 2000, pp. 56-57

Authors: Regnault, V De Maistre, E Wahl, D Lecompte, T
Citation: V. Regnault et al., Monovalent binding of autoantibodies to beta(2)-glycoprotein I, detected using surface plasmon resonance at low antigen density, BR J HAEM, 109(1), 2000, pp. 187-194

Authors: Latger, V Dumas, D Lecompte, T Potron, G Stoltz, JF
Citation: V. Latger et al., Vascular disease and cell activation: exploration of cell adhesion phenotype by quantitative flow cytometry., J MAL VASC, 24(1), 1999, pp. 11-18

Authors: Lepaux, DJ Wahl, D Briancon, S Lecompte, T
Citation: Dj. Lepaux et al., Improvement of prophylaxis of venous thromboembolism in patients. A mission impossible?, REV MED IN, 20(9), 1999, pp. 785-793

Authors: Nguyen, P De Maistre, E Cornillet-Lefebvre, P Regnault, V Lecompte, T
Citation: P. Nguyen et al., Heparin-induced thrombocytopenia in France, 1980-1998, SEM THROMB, 25, 1999, pp. 9-15

Authors: Regnault, V Arvieux, J Vallar, L Lecompte, T
Citation: V. Regnault et al., Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta(2)-glycoprotein I, IMMUNOLOGY, 97(3), 1999, pp. 400-407

Authors: Helft, G Elalamy, I Beygui, F Dambrin, G Lecompte, T Le Pailleur, C Le Feuvre, C Metzger, JP Vacheron, A Samama, MM
Citation: G. Helft et al., New thrombolytic agents in myocardial infarction., ARCH MAL C, 92(4), 1999, pp. 411-417

Authors: Lecompte, T de Maistre, E Wahl, D
Citation: T. Lecompte et al., Heparin-induced thrombocytopenia: new treatments, REV MED IN, 19(11), 1998, pp. 783-786
Risultati: 1-25 | 26-28